Trinity Capital Inc. — Form 8-K Summary
Business Context and Reporting Period
Trinity Capital Inc. filed a Form 8-K regarding its 2022 Annual Meeting of Stockholders held on June 8, 2022. The company is a Maryland corporation whose common stock trades on the Nasdaq Global Select Market under the symbol TRIN. The filing was signed on June 13, 2022.
Financial Metrics and Capitalization
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, net asset value, or other operating financial metrics. As of the April 11, 2022 record date, 30,737,682 common shares were outstanding and entitled to vote.
Material Changes and Meeting Results
- Director elections: Stockholders re-elected Steven L. Brown and Irma Lockridge to terms expiring at the 2025 Annual Meeting, and Richard P. Hamada to a term expiring at the 2024 Annual Meeting, in each case until successors are elected and qualified.
- Votes for Steven L. Brown: 13,608,615 for, 2,958,394 against, and 36,044 abstentions.
- Votes for Irma Lockridge: 14,436,354 for, 1,844,483 against, and 322,216 abstentions.
- Votes for Richard P. Hamada: 15,490,005 for, 1,077,893 against, and 35,155 abstentions.
- Issuance below net asset value: Stockholders approved authorization for the company to sell or otherwise issue up to 25% of then-outstanding common shares at a price below the then-current net asset value per share.
- Proposal 2 vote: All stockholders voted 13,113,743 for, 2,653,456 against, and 835,854 abstentions. Stockholders without affiliates voted 10,984,224 for, 2,653,456 against, and 835,854 abstentions.
- The filing reports no broker non-votes for the listed proposals.
Guidance, Outlook, Risks, and Unusual Items
The filing contains no financial guidance or management outlook. The approved authority to issue shares below net asset value could result in dilution to existing stockholders and is subject to the terms described in the company’s proxy materials. The filing text does not provide additional conditions or planned issuance amounts.
Key Facts for Investor Verification
- Verify the scope and duration of the authorization to issue shares below net asset value in the April 27, 2022 definitive proxy statement.
- Monitor any future equity offerings, pricing relative to net asset value, and potential dilution.
- Confirm the elected directors’ committee assignments and governance roles in subsequent filings.
- Review subsequent Form 8-K and periodic reports for any exercise of the share-issuance authorization or related capital-markets activity.